Clinical trial

Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma Versus Combined of Both on Serum Adiponectin Level in Alopecia Areata

Name
Faten Othman
Description
Alopecia areata (AA) is a common, immune-mediated non scarring alopecia and can be associated with severe psychological consequences . Alopecia Areata affects 2% of the global population. Alopecia Areata prevalence is lower in adults than children, is increasing over time, and significantly differs by region. Its etiology is unknown but it was hypothesized to be an autoimmune disease mediated by T-lymphocytes. It has been suggested that inflammatory T cells induce growth arrest in hair bulbs in the anagen phase of the hair cycle . Cytotoxic T cells secrete tumor necrosis factor, granzymes, and Fas ligand which trigger apoptosis in affected hair follicle and disrupt hair growth
Trial arms
Trial start
2023-07-01
Estimated PCD
2023-10-01
Trial end
2023-10-15
Status
Completed
Treatment
Calcipotriol
To evaluate the efficacy of Calcipotriol on Alopecia Areata.
Arms:
Group A, Group B, Group C, Group D
Other names:
Platelet Rich Plasma
Size
80
Primary endpoint
Efficacy of topical calcipotriol and platelet Rich Plasma in Alopecia Areata treatment
from baseline to 3 months
Eligibility criteria
Inclusion Criteria: * Patients with non-severe alopecia areata , a severity of alopecia tool (SALT) score up to 2 with less than 50% of scalp involvement. * No restriction of age , race, nor occupation Exclusion Criteria: 1. Pregnant and lactating women, immunocompromised patients. 2. Patients having active scalp inflammation. 3. Patients who received systemic treatment for Alopecia Areata in the last 3 months or applied any topical or intradermal treatments in the last 4 weeks .
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 80, 'type': 'ACTUAL'}}
Updated at
2023-10-19

1 organization

1 product

1 indication

Organization
Egymedicalpedia
Indication
Alopecia Areata